GENinCode plc
Company Profile
Company website
Sector
Medical Equipment and Services (Medical Services)
Description
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.
.jpg "GENI - interim presentations (20.09.23)")
Investor Access
20
Sep
Event information
The Company will be announcing its interim results for the six months ended 30 June 2023 on Wednesday 20 September 2023.
Investors can sign up to Investor Meet Company for free and add to meet GENinCode PLC via the following link:
https://www.investormeetcompany.com/genincode-plc/register-investorVenue
Online
Time
Wednesday 20 September 2023 at 4:30pm
Financial Calendar
| Event | Date |
| Year End | December 31 |
| Half Year End | 30 June |
| Preliminary Results* | March/April |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
